TB-ADC-01

N/A

Report date: 2023/12/12 16:50:19

Base Information

Drug NameTB-ADC-01

Drug Alias NameTB-ADC-01

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionMucin-13 modulators

TargetsMucin-13

Therapy Area/IndicationsColorectal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTheragen Bio Co Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsColorectal Neoplasms

Inactive IndicationsN/A

ATC CodeN/A